Log In or Create Account
Resistance Mutations
Podcasts
Key Slides
Question of the Week
CROI
RWHAP Clinical Conference
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
DEA-Compliant CME Resource Center For HIV Clinicians
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
Did You Know?
FAQs
Fellow/Student Resources
Fellow/Student Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Mission
Scientific Leadership Board
Core Faculty
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Menu
Peter L. Anderson, PharmD
Peter L. Anderson, PharmD
University of Colorado
Professor of Medicine
University of Colorado
Resistance Mutations
Podcasts
Key Slides
Question of the Week
CROI
RWHAP Clinical Conference
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
DEA-Compliant CME Resource Center For HIV Clinicians
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
Did You Know?
FAQs
Fellow/Student Resources
Fellow/Student Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Mission
Scientific Leadership Board
Core Faculty
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Practice Question of the Week
September 25, 2023: Counseling Patients on Doxy-PEP
Which of the following should be given as guidance when prescribing doxycycline postexposure prophylaxis (doxy-PEP)?
A. Doxycycline should
not
be given with ritonavir-boosted HIV protease inhibitors
B. Doxycycline may protect against mpox
C. Doxycycline should
not
be given with tenofovir-containing HIV preexposure prophylaxis
D. Doxycycline should
not
be taken at the same time as bivalent-containing antacids, multivitamins, or calcium supplements
E. Doxycycline should
not
be taken with acid-blocking medications like proton-pump inhibitors and histamine-2 blockers
Register for the Webinar
View Archived Questions
Leave Feedback
Subscribe
CLOSE
